1. Home
  2. OPTX vs CTSO Comparison

OPTX vs CTSO Comparison

Compare OPTX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • CTSO
  • Stock Information
  • Founded
  • OPTX 1981
  • CTSO 1997
  • Country
  • OPTX United States
  • CTSO United States
  • Employees
  • OPTX N/A
  • CTSO N/A
  • Industry
  • OPTX Blank Checks
  • CTSO Medical/Dental Instruments
  • Sector
  • OPTX Finance
  • CTSO Health Care
  • Exchange
  • OPTX Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • OPTX 51.7M
  • CTSO 52.6M
  • IPO Year
  • OPTX N/A
  • CTSO N/A
  • Fundamental
  • Price
  • OPTX $1.30
  • CTSO $1.03
  • Analyst Decision
  • OPTX
  • CTSO Buy
  • Analyst Count
  • OPTX 0
  • CTSO 2
  • Target Price
  • OPTX N/A
  • CTSO $5.50
  • AVG Volume (30 Days)
  • OPTX 53.3K
  • CTSO 137.4K
  • Earning Date
  • OPTX 08-13-2025
  • CTSO 08-12-2025
  • Dividend Yield
  • OPTX N/A
  • CTSO N/A
  • EPS Growth
  • OPTX N/A
  • CTSO N/A
  • EPS
  • OPTX 0.00
  • CTSO N/A
  • Revenue
  • OPTX $29,392,186.00
  • CTSO $35,332,238.00
  • Revenue This Year
  • OPTX N/A
  • CTSO $18.34
  • Revenue Next Year
  • OPTX N/A
  • CTSO $19.82
  • P/E Ratio
  • OPTX $798.92
  • CTSO N/A
  • Revenue Growth
  • OPTX 4.00
  • CTSO 15.37
  • 52 Week Low
  • OPTX $0.85
  • CTSO $0.71
  • 52 Week High
  • OPTX $5.10
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 41.18
  • CTSO 45.35
  • Support Level
  • OPTX $1.36
  • CTSO $0.93
  • Resistance Level
  • OPTX $1.39
  • CTSO $1.16
  • Average True Range (ATR)
  • OPTX 0.07
  • CTSO 0.08
  • MACD
  • OPTX 0.00
  • CTSO -0.02
  • Stochastic Oscillator
  • OPTX 12.50
  • CTSO 27.22

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: